Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 3Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Genitourinary 5Thoracic 3Dermatologic 2Plasma cell 1Other neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Melanoma 1486Lymphoma, T-Cell, Cutaneous 313Skin Neoplasms 268Keratosis, Actinic 249Mycosis Fungoides 224Sezary Syndrome 216Lymphoma, Non-Hodgkin 206Leukemia, Lymphocytic, Chronic, B-Cell 200Lymphoma, Large B-Cell, Diffuse 198Lymphoma, Follicular 196Neoplasms 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, B-Cell, Marginal Zone 192Lymphoma, Mantle-Cell 191Hodgkin Disease 191Carcinoma, Basal Cell 190Breast Neoplasms 185Burkitt Lymphoma 184Lymphoma 182Lymphoma, Large-Cell, Immunoblastic 177Carcinoma, Non-Small-Cell Lung 150Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 140Lymphoma, Large-Cell, Anaplastic 137Multiple Myeloma 133Carcinoma, Renal Cell 128Immunoblastic Lymphadenopathy 126Uveal Melanoma 125Neoplasm Metastasis 120Leukemia, Myeloid, Acute 113Waldenstrom Macroglobulinemia 103

Interventions

Bandages, Hydrocolloid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Patient Preference × Dermatologic × Clear all
NCT05618912 2024-12-11

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment

Indiana University

Phase NA Completed
146 enrolled 9 charts
Dermatologic

Surgical Wound, Cicatrix, Skin Neoplasms, Patient Satisfaction, Patient Preference

NCT05115006 2022-06-30

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Bristol-Myers Squibb

Completed
294 enrolled
Dermatologic

Melanoma, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡